Persistent URL of this record https://hdl.handle.net/1887/116021
In Collections
This item can be found in the following collections:
The BRCA1 c. 5096G > A p.Arg1699Gln (R1699Q) intermediate risk variant: breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium
- All authors
- Moghadasi, S.; Meeks, H.D.; Vreeswijk, M.P.G.; Janssen, L.A.M.; Borg, A.; Ehrencrona, H.; Paulsson-Karlsson, Y.; Wappenschmidt, B.; Engel, C.; Gehrig, A.; Arnold, N.; Hansen, T.V.; Thomassen, M.; Jensen, U.B.; Kruse, T.A.; Ejlertsen, B.; Gerdes, A.M.; Pedersen, I.S.; Caputo, S.M.; Couch, F.; Hallberg, E.J.; Ouweland, A.M.W. van den; Collee, M.J.; Teugels, E.; Adank, M.A.; Luijt, R.B. van der; Mensenkamp, A.R.; Oosterwijk, J.C.; Blok, M.J.; Janin, N.; Claes, K.B.M.; Tucker, K.; Viassolo, V.; Toland, A.E.; Eccles, D.E.; Devilee, P.; Asperen, C.J. van; Spurdle, A.B.; Goldgar, D.E.; Garcia, E.G.
- Date
- 2018-01-31
- Journal
- Journal of Medical Genetics
- Volume
- 55
- Issue
- 1
- Pages
- 15 - 20